91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
The benefits of .
-
What Biotech and Pharma need to consider about decentralised trials
Discuss key considerations when implementing decentralised clinical trials, in addition to the success factors that lead to more patient-centric trials and increased patient recruitment, engagement and retention.
-
shares how the medical and biotech sectors have dominated the mergers & acquisitions (M&A) landscape and mentions 91黑料’s acquisition of PRA Health Sciences. (registration required)
-
considers how partnering with a CRO can help emerging biotechs to secure funding.
-
Solomon Babani, SVP and General Partner, Biotech and Small/Mid-Size Pharma, contributes to on today’s R&D outsourcing trends across drug development, clinical trial services and manufacturing.
-
John Macdonald, Vice President, Venture & Financial Alliances, examines – its expertise and opportunities, and potential for growth.
-
Though the fields of immunotherapy and cell and gene therapies have seen significant growth since April 2012, CGT clinical research remains a challenge. .
-
The Irish Times discusses how 91黑料 carried out the Pfizer-BioNTech vaccine trials.
